Abstract
Aim: To externally validate a prediction model that identifies adverse outcomes in hospitalised patients with diabetes.
Methods: Data source: Inpatient data for 2014 from Heart of England Foundation Trust (HEFT) and Ipswich General Hospital.
Participants: Patients with a diagnostic code of diabetes.
Candidate variables: Age; gender; ethnicity; admission type; ITU admission; insulin therapy; albumin; sodium; potassium; haemoglobin; C-Reactive Protein; Estimated Glomerular Filtration Rate; and neutrophil count.
Outcome definition: Adverse outcome is a composite outcome (excessive length of stay or death).
Performance assessment: To assess discrimination, a receiver operating characteristic curve was constructed and Area Under the Curve (AUC) calculated. Calibration was assessed by plotting predicted probabilities of outcome against observed probabilities of outcome.
Results: There were 16,568 admissions with diabetes to HEFT in 2014. The model discriminated well between those with and without an adverse outcome in HEFT (AUC:0.758, 95% CI: 0.747–0.768; sensitivity: 72.6%; specificity: 66.0%; and Positive Predictive Value (PPV): 45.1%). These are in comparison to the internally validated model derived at University Hospitals Birmingham NHS Foundation Trust (AUC: 0.802; sensitivity: 76%; specificity: 70%; and PPV: 49%). Calibration plot suggested predicted probabilities were similar to observed probabilities. Ipswich General Hospital produced comparable results to that of HEFT.
Conclusion: The externally validated prediction model is a novel tool that can be used to improve care pathways for inpatients with diabetes. Further research utilising the model to develop care pathways and assess clinical utility is needed.
Methods: Data source: Inpatient data for 2014 from Heart of England Foundation Trust (HEFT) and Ipswich General Hospital.
Participants: Patients with a diagnostic code of diabetes.
Candidate variables: Age; gender; ethnicity; admission type; ITU admission; insulin therapy; albumin; sodium; potassium; haemoglobin; C-Reactive Protein; Estimated Glomerular Filtration Rate; and neutrophil count.
Outcome definition: Adverse outcome is a composite outcome (excessive length of stay or death).
Performance assessment: To assess discrimination, a receiver operating characteristic curve was constructed and Area Under the Curve (AUC) calculated. Calibration was assessed by plotting predicted probabilities of outcome against observed probabilities of outcome.
Results: There were 16,568 admissions with diabetes to HEFT in 2014. The model discriminated well between those with and without an adverse outcome in HEFT (AUC:0.758, 95% CI: 0.747–0.768; sensitivity: 72.6%; specificity: 66.0%; and Positive Predictive Value (PPV): 45.1%). These are in comparison to the internally validated model derived at University Hospitals Birmingham NHS Foundation Trust (AUC: 0.802; sensitivity: 76%; specificity: 70%; and PPV: 49%). Calibration plot suggested predicted probabilities were similar to observed probabilities. Ipswich General Hospital produced comparable results to that of HEFT.
Conclusion: The externally validated prediction model is a novel tool that can be used to improve care pathways for inpatients with diabetes. Further research utilising the model to develop care pathways and assess clinical utility is needed.
Original language | English |
---|---|
Article number | A4 (P376) |
Pages (from-to) | 6 |
Number of pages | 1 |
Journal | Diabetic Medicine |
Volume | 34 |
Issue number | Suppl. 1 |
DOIs | |
Publication status | Published - 8 Mar 2017 |
Keywords
- diabetes
- Inpatient
- Prediction model
- validation